| Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers J Adamski, B Godman, G Ofierska-Sujkowska, B Osińska, H Herholz, ... BMC health services research 10, 1-16, 2010 | 340 | 2010 |
| Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010 | 210 | 2010 |
| Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018 | 179 | 2018 |
| Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ... Expert review of clinical pharmacology 8 (1), 77-94, 2015 | 168 | 2015 |
| Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ... Frontiers in pharmacology 5, 106, 2014 | 166 | 2014 |
| Policies to enhance prescribing efficiency in Europe: findings and future implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Frontiers in pharmacology 1, 141, 2011 | 154 | 2011 |
| Ongoing pharmaceutical reforms in France: implications for key stakeholder groups C Sermet, V Andrieu, B Godman, E Van Ganse, A Haycox, JP Reynier Applied health economics and health policy 8, 7-24, 2010 | 150 | 2010 |
| Women's health in relation with their family and work roles: France in the early 1990s M Khlat, C Sermet, A Le Pape Social science & medicine 50 (12), 1807-1825, 2000 | 147 | 2000 |
| Trends in the prevalence of obesity in the French adult population between 1980 and 1991 G Maillard, MA Charles, N Thibult, A Forhan, C Sermet, A Basdevant, ... International journal of obesity 23 (4), 389-394, 1999 | 139 | 1999 |
| Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population M Herr, N Sirven, H Grondin, S Pichetti, C Sermet European journal of clinical pharmacology 73, 1165-1172, 2017 | 131 | 2017 |
| Use of generics—a critical cost containment measure for all healthcare professionals in Europe? B Godman, W Shrank, B Wettermark, M Andersen, I Bishop, T Burkhardt, ... Pharmaceuticals 3 (8), 2470-2494, 2010 | 131 | 2010 |
| Personalizing health care: feasibility and future implications B Godman, AE Finlayson, PK Cheema, E Zebedin-Brandl, ... BMC medicine 11, 1-23, 2013 | 129 | 2013 |
| Obesity morbidity and health care costs in France: an analysis of the 1991–1992 Medical Care Household Survey B Detournay, F Fagnani, M Phillippo, C Pribil, MA Charles, C Sermet, ... International journal of obesity 24 (2), 151-155, 2000 | 128 | 2000 |
| Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs RE Malmström, BB Godman, E Diogene, C Baumgärtel, M Bennie, ... Frontiers in pharmacology 4, 39, 2013 | 122 | 2013 |
| Consommations et prescriptions pharmaceutiques chez les personnes âgées L Auvray, C Sermet Gérontologie et société 25103 (4), 13-27, 2002 | 114 | 2002 |
| Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review B Parkinson, C Sermet, F Clement, S Crausaz, B Godman, S Garner, ... Pharmacoeconomics 33, 905-924, 2015 | 110 | 2015 |
| Trends in antimicrobial drug use in the community—France, 1981–1992 D Guillemot, P Maison, C Carbon, B Balkau, F Vauzelle-Kervroëdan, ... Journal of Infectious Diseases 177 (2), 492-497, 1998 | 107 | 1998 |
| Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France M Khlat, C Sermet, A Le Pape European journal of epidemiology 19, 445-451, 2004 | 106 | 2004 |
| Évaluation du coût associé à l’obésité en France C Emery, A Lafuma, B Khoshnood, F Fagnani, J Dinet, C Sermet Médecine des maladies Métaboliques 1 (2), 28-34, 2007 | 103 | 2007 |
| Examination of the causes and mechanisms of the increase in disability-free life expectancy JM Robine, P Mormiche, C Sermet Journal of Aging and Health 10 (2), 171-191, 1998 | 101 | 1998 |
